Plasma cytokine levels before and 1 year after successful living-donor renal transplantation

Abstract Purpose This study aimed to evaluate cytokine levels in plasma samples over time from living-donor renal transplant recipients with no evidence of pathological and clinical rejection at least 1 year post-procedure. Methods We examined plasma cytokine levels in 15 living-donor renal transpla...

Full description

Bibliographic Details
Main Authors: Ayato Ito, Jun Sugimura, Tomohiko Matsuura, Takaya Abe, Wataru Obara
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Renal Replacement Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41100-020-00298-5
id doaj-9e157113e16048be887a106130df72e8
record_format Article
spelling doaj-9e157113e16048be887a106130df72e82020-11-25T03:59:54ZengBMCRenal Replacement Therapy2059-13812020-11-01611910.1186/s41100-020-00298-5Plasma cytokine levels before and 1 year after successful living-donor renal transplantationAyato Ito0Jun Sugimura1Tomohiko Matsuura2Takaya Abe3Wataru Obara4Department of Urology, Iwate Medical UniversityDepartment of Urology, Iwate Medical UniversityDepartment of Urology, Iwate Medical UniversityDepartment of Urology, Iwate Medical UniversityDepartment of Urology, Iwate Medical UniversityAbstract Purpose This study aimed to evaluate cytokine levels in plasma samples over time from living-donor renal transplant recipients with no evidence of pathological and clinical rejection at least 1 year post-procedure. Methods We examined plasma cytokine levels in 15 living-donor renal transplant recipients who were treated at our hospital from 2015 to 2018 and who presented with no evidence of pathological or clinical rejection for 1 year or longer. We collected blood samples before renal transplantation and at 1 week and 1 year post-procedure. We evaluated levels of 40 cytokines in plasma using Bio-Plex Pro™ Human Chemokine Assay kit. Results We detected no increase in plasma cytokine levels at either the 1 week or the 1 year time points. Plasma levels of 22 cytokines remained stable throughout and levels of 18 cytokine decreased after transplantation. Conclusion Plasma cytokine levels remained unchanged or were decreased in our patient cohort that included stable cases of living-donor renal transplantation. Our results suggest that renal transplantation may promote amelioration of chronic inflammation associated with end-stage renal failure and dialysis.http://link.springer.com/article/10.1186/s41100-020-00298-5CytokineRenal transplantationChronic rejectionUremiaDialysis
collection DOAJ
language English
format Article
sources DOAJ
author Ayato Ito
Jun Sugimura
Tomohiko Matsuura
Takaya Abe
Wataru Obara
spellingShingle Ayato Ito
Jun Sugimura
Tomohiko Matsuura
Takaya Abe
Wataru Obara
Plasma cytokine levels before and 1 year after successful living-donor renal transplantation
Renal Replacement Therapy
Cytokine
Renal transplantation
Chronic rejection
Uremia
Dialysis
author_facet Ayato Ito
Jun Sugimura
Tomohiko Matsuura
Takaya Abe
Wataru Obara
author_sort Ayato Ito
title Plasma cytokine levels before and 1 year after successful living-donor renal transplantation
title_short Plasma cytokine levels before and 1 year after successful living-donor renal transplantation
title_full Plasma cytokine levels before and 1 year after successful living-donor renal transplantation
title_fullStr Plasma cytokine levels before and 1 year after successful living-donor renal transplantation
title_full_unstemmed Plasma cytokine levels before and 1 year after successful living-donor renal transplantation
title_sort plasma cytokine levels before and 1 year after successful living-donor renal transplantation
publisher BMC
series Renal Replacement Therapy
issn 2059-1381
publishDate 2020-11-01
description Abstract Purpose This study aimed to evaluate cytokine levels in plasma samples over time from living-donor renal transplant recipients with no evidence of pathological and clinical rejection at least 1 year post-procedure. Methods We examined plasma cytokine levels in 15 living-donor renal transplant recipients who were treated at our hospital from 2015 to 2018 and who presented with no evidence of pathological or clinical rejection for 1 year or longer. We collected blood samples before renal transplantation and at 1 week and 1 year post-procedure. We evaluated levels of 40 cytokines in plasma using Bio-Plex Pro™ Human Chemokine Assay kit. Results We detected no increase in plasma cytokine levels at either the 1 week or the 1 year time points. Plasma levels of 22 cytokines remained stable throughout and levels of 18 cytokine decreased after transplantation. Conclusion Plasma cytokine levels remained unchanged or were decreased in our patient cohort that included stable cases of living-donor renal transplantation. Our results suggest that renal transplantation may promote amelioration of chronic inflammation associated with end-stage renal failure and dialysis.
topic Cytokine
Renal transplantation
Chronic rejection
Uremia
Dialysis
url http://link.springer.com/article/10.1186/s41100-020-00298-5
work_keys_str_mv AT ayatoito plasmacytokinelevelsbeforeand1yearaftersuccessfullivingdonorrenaltransplantation
AT junsugimura plasmacytokinelevelsbeforeand1yearaftersuccessfullivingdonorrenaltransplantation
AT tomohikomatsuura plasmacytokinelevelsbeforeand1yearaftersuccessfullivingdonorrenaltransplantation
AT takayaabe plasmacytokinelevelsbeforeand1yearaftersuccessfullivingdonorrenaltransplantation
AT wataruobara plasmacytokinelevelsbeforeand1yearaftersuccessfullivingdonorrenaltransplantation
_version_ 1724452431744466944